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Background. Neuropathy is one of the most common, debilitating complications of diabetes mellitus, often neglect-
ed in routine diabetes treatment. It is the single most common reason for foot ulcerations and amputations and is responsible 
for severe sensory abnormalities and reduced quality of life among thousands of diabetic patients.
Objectives. The aim of our study was to establish the prevalence and type of peripheral neuropathy in diabetic patients by 
means of nerve conduction studies (NCSs) in order to encourage primary care physicians to look for any signs of sensory or 
motor abnormalities early in the management of diabetes, thus preventing irreversible nerve damage.
Material and methods. A total of 21 patients with type 2 diabetes (12 men and 9 women; mean age, 60.8 ± 8.9 years) present-
ing with neuropathy symptoms were enrolled into the study. Sensory and motor NCSs were conducted in the ulnar, median, 
peroneal, sural, and tibial nerves.
Results. Sensory axonal polyneuropathy was diagnosed in 7 patients; sensory and motor polyneuropathy, in 2 patients; and 
carpal tunnel syndrome, in 3 patients. In the remaining patients, the results of NCSs were within the reference range.
Conclusions. The study revealed that 12 patients (57%) had nerve conduction abnormalities suggesting peripheral nerve chang-
es and polyneuropathy. In addition, our study confirmed that NCSs are useful in assessing the prevalence of neuropathy and dif-
ferentiating between axonal and demyelination polyneuropathies and various types of mononeuropathies in diabetic patients 
and should be part of routine primary care protocols in the management of diabetes.
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Wstęp. Neuropatia jest jedną z najczęstszych, najbardziej uciążliwych powikłań cukrzycy, często zaniedbywa-
na podczas rutynowych kontroli lekarskich. Neuropatia jest najczęstszą przyczyną owrzodzeń oraz amputacji stóp oraz przy-
czynia się do ciężkich zaburzeń czucia i obniżonej jakości życia tysięcy pacjentów z cukrzycą. Wczesne wykrycie oraz odpo-
wiednio szybko podjęte leczenie jest kluczowe w złagodzenia objawów i zahamowaniu postępu choroby, zapobiegając w ten 
sposób trwałym, nieodwracalnym uszkodzeniom nerwów
Cel pracy. Określenie przydatności badania przewodzenia nerwowego (NCS) w ocenie częstości występowania neuropatii 
oraz określenia jej rodzaju u chorych na cukrzycę, tak aby zwiększyć świadomość lekarzy pierwszego kontaktu o istocie pro-
blemu i uczulić na towarzyszące cukrzycy objawy zaburzeń układu nerwowego.
Materiał  i  metody. W badaniu wzięło udział dwudziestu jeden pacjentów chorych na cukrzycę typu 2 (12 mężczyzn i 9 ko-
biet; średnia wieku 60,8 ± 8,9 roku) z objawami neuropatii. Wykonano badanie przewodzenia czuciowego (SNCS) w ner-
wach: łokciowym, pośrodkowym, strzałkowym powierzchownym i łydkowym oraz badanie przewodzenia ruchowego (MNCS) 
w nerwach: łokciowym, pośrodkowym, strzałkowym i piszczelowym z uwzględnieniem fali F. U wszystkich chorych przepro-
wadzono wcześniej kliniczne badanie neurologiczne.
Wyniki. Zespół cieśni nadgarstka rozpoznano u trzech pacjentów, aksonalną polineuropatię czuciową rozpoznano u siedmiu 
pacjentów, a polineuropatię czuciowo-ruchową typu aksonalno-demielinizacyjnego – u dwóch pacjentów. U pozostałych pa-
cjentów parametry przewodzenia były prawidłowe.
Wnioski. Wyniki wykazały, że neuropatia występuje powszechnie u chorych na cukrzycę oraz potwierdziły przydatność ba-
dania neurograficznego w ocenie występowania, a także rozpoznawania odmiennych typów neuropatii cukrzycowej od po-
lineuropatii aksonalnych i demielinizacyjnych oraz różnego rodzaju mononeuropatii. Opierając się na naszych wynikach po-
stulujemy, aby badanie neurograficzne stanowiło integralną część badań podstawowych przy leczeniu cukrzycy.
Słowa kluczowe: cukrzyca typu 2, badanie neurograficzne, polineuropatia cukrzycowa.
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Background
Diabetic neuropathy is the most common neurological 
complication of diabetes, affecting up to 50% of all diabetic 
patients worldwide. Research on the population in Roches-
ter found that 1.3% of individuals had diabetes, of which 
54% presented with symptoms of polyneuropathy (7 in 
every 1.000 persons). Diabetic neuropathy is a significant 
problem for primary care practitioners. According to studies 
of Italian primary care practitioners, its prevalence in a pop-
ulation over 55 years of age reaches 1%. The prevalence rate 
increases with age and duration of the disease [1, 2].
Sensorimotor peripheral polyneuropathy is the most 
common type of diabetic neuropathy. Comorbidities often 
include autonomic neuropathy. The onset of the disease is 
usually insidious. 
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Patients with diabetic neuropathy typically have sym-
metric numbness, tingling, and pain (stocking and glove 
distribution). The sensory symptoms include those linked to 
thick fibers, such as a decrease of tendon reflexes and vibra-
tory sensation in the leg.
Moderate and severe diabetic neuropathy is associated 
with the risk of weakness in the feet that spreads proximally. 
It is the single most common reason for foot ulcerations and 
amputations and is responsible for severe sensory abnor-
malities and reduced quality of life in thousands of diabetic 
patients [3–5]. Early detection and treatment is the key to 
alleviating symptoms of neuropathy and stopping the pro-
gression of the disease, which prevents permanent and ir-
reversible nerve damage [6]. 
Routine monitoring of diabetic patients is often limited 
to a regular measurement of blood glucose levels and car-
diovascular checkup, often neglecting the follow-up of other 
possibly affected systems such as the peripheral nervous sys-
tem. Diabetic patients are referred to neurological clinics 
only when neuropathy symptoms are already severe and dif-
ficult to manage [7]. 
A nerve conduction study (NCS) is a reliable, noninva-
sive, and highly reproducible method that is routinely used 
in the diagnosis of peripheral nerve disorders. The utility 
of NCSs for detecting peripheral nerve changes has been 
shown in numerous disorders, allowing for the implementa-
tion of relevant treatment protocols and prevention of further 
damage. Abnormalities in the sensory fibers occur in 89% 
of patients with clinical symptoms of polyneuropathy, while 
those in the motor fibers – in 78% to 80% of the patients. 
Axonal injury occurs first, while segmental demyelination 
is secondary. A reduction in nerve conduction velocity by 
more than 20% to 30% of the normal value is caused by the 
coexistent demyelination and metabolic factors [8, 9].
Objectives
The aim of our study was to establish the prevalence and 
type of peripheral neuropathy in patients with type 2 diabe-
tes using the NCS in order to encourage primary care physi-
cians to examine any signs of sensory or motor abnormali-
ties early in the diabetes treatment to prevent irreversible 
and debilitating nerve damage.  
Material and methods
Subjects
The study included 21 patients with type 2 diabetes 
(12 men and 9 women; mean age, 60.8 ± 8.9 years). The 
duration of type 2 diabetes ranged from 7 weeks to 25 years. 
Patients did not have any other risk factors for neuropathy. 
All patients reported symptoms suggesting neuropathy, such 
as dysesthesia, numbness, or sensory loss in the feet or 
hands (or both). 
A neurological examination revealed abnormalities in 
12 patients, including a decrease in ankle jerks and vibra-
tory sensation in the legs. Additionally, in 6 of these pa-
tients, sensory loss was observed, with symmetrical glove 
and stocking distribution. 
All patients provided written informed consent to partici-
pate in the study, and the study protocol was approved by 
the local ethics committee. 
Stimulation technique
NCSs were conducted according to standard procedures 
using the Viking Quest device (Nicolet Biomedical Incorpo-
rated, Madison, WI, USA). 
Sensory NCSs (SNCSs) were conducted in the ulnar, me-
dial, sural, and peroneal nerves. A median sensory NCS was 
recorded with wire electrodes from the second digit anti-
dromically with a standard distance of 13 cm, and the fifth 
digit with a standard distance of 12 cm. In the lower extremi-
ties, the antidromic method was used to stimulate the sural 
nerve laterally to the midline of the calf muscles and the su-
perficial peroneal nerve with stimulation electrodes placed 
against the anterior edge of the fibula. 
Motor NCSs (MNCSs) were conducted in the ulnar, me-
dian, peroneal, and tibial nerves with a single stimulus and 
with a stimulation rate of 1 Hz to obtain the F wave. In the 
upper extremities, stimulations were conducted over the 
left ulnar and right median nerves. In the lower extremities, 
stimulations were conducted over the right peroneal and 
left tibial nerves. The intensity of the current and the site 
of stimulation were set according to the standard protocol. 
Supramaximal, constant-current bipolar stimulation was 
conducted using a bar electrode and ring electrodes. SNCSs 
were conducted using a stimulation rate of 2 Hz, while 
MNCSs – using single, rectangular pulses. The stimulus du-
ration was 0.2 ms.
Data analyses
Only descriptive statistics were used in the study. 
Results
Clinical examination
All patients reported symptoms suggesting neuropathy, 
such as dysesthesia, numbness, or sensory loss in the feet 
or hands (or both). Two patients also reported distal muscle 
limb weakness. 
A neurological examination revealed abnormalities in 
21 patients, such as a decrease in ankle jerks or vibratory 
sensation in the legs (12 patients), sensory loss in the distal 
parts of the limbs (7 patients), or weakness and atrophy of 
the distal muscles of the limbs (2 patients). 
Laboratory tests showed normal levels of creatinine 
phosphokinase and hepatic and thyroid enzymes. 
Electrophysiological examination
A reduction in the amplitude of sensory nerve action 
potentials (SNAPs) and compound muscle action potentials 
in the lower limbs was the most common and was more 
advanced than the generally normal or moderate reduction 
in sensory and motor fiber conduction velocity. The lack of 
excitability in single nerves was diagnosed in 3 patients. We 
confirmed the lack of SNAPs in the sural nerve in 1 patient 
and in the superficial peroneal nerve in 2 patients. None of 
the patients showed signs of conduction block. 
Sensory axonal polyneuropathy was diagnosed in 7 pa-
tients; sensory and motor polyneuropathy, in 2 patients; and 
compression mononeuropathies such as carpal tunnel syn-
drome, in 3 patients (Tab. 1). In the remaining patients, the 
results of the SNCSs and MNCSs were within the reference 
range. 
Discussion
Our study revealed that 12 patients (57%) had nerve con-
duction abnormalities suggesting peripheral nerve changes 
and polyneuropathy. In the remaining patients, despite clini-
cal manifestations of neuropathy, the NCS did not show any 
abnormalities, suggesting that the underlying nerve changes 
present in these patients were likely limited to small fibers, 
undetectable by standard NCSs [6, 8]. 
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Diabetic neuropathy is characterized by a decrease in 
nerve conduction velocity and nerve action potential due 
to axonal loss and fiber demyelination [10, 11]. NCSs are 
a helpful tool in the early diagnosis of peripheral neuropa-
thies in diabetic patients. A large cohort study, conducted 
on several thousands of diabetic patients, indicated that 
an NCS is the single most reliable predictor of neuropathy 
risks and could be used as a valuable risk assessment tool 
differentiating patients according to the risk of neuropathy 
development, allowing for the implementation of relevant 
treatment protocols. The final type of neuropathy is also in-
fluenced by genetic factors and the age of patients, which 
condition individual sensitivity to tissue injury, depending 
on hyperglycemia or hyperinsulinemia [6]. 
NCSs are very accurate in the early diagnosis of large 
fiber focal lesions and are particularly useful in a differential 
diagnosis between axonal and demyelinating neuropathies, 
both of which require different management and treatment 
protocols [8]. In our study, patients with detected neuro-
graphic abnormalities showed signs of axonal (mainly sen-
sory) polyneuropathy or carpal tunnel syndrome (or both), 
confirming the results of clinical observations and sup-
porting the role of an NCS in the diagnosis of neuropathy. 
However, we were unable to detect any nerve conduction 
changes in the remaining patients. Based on our previous 
studies and reports by other authors, it might be speculated 
that those patients suffered from small-fiber sensory neurop-
athy that requires a collection of nerve biopsies and a subse-
quent histological examination in order to establish a proper 
diagnosis [12, 13]. 
Limitations of the study 
Our study also indicated that NCSs have their limita-
tions. In particular, they fail to detect small-fiber neuropa-
thies, in which case additional diagnostic techniques such 
as quantitative sensory testing and skin biopsy with quan-
tification of somatic intraepidermal nerve fibers should be 
used. Because the study group was small, the clinical and 
electrophysiological correlations were not assessed. Our 
findings are preliminary.
Conclusions
Our results showed that an NCS is a reliable tool in es-
tablishing the diagnosis and determining the type of neu-
ropathy, differentiating between axonal and demyelination 
polyneuropathies and different types of mononeuropathies. 
Based on our results, we believe that NCSs, despite their 
limitations, should be a part of routine primary care pro-
tocols in the management of diabetes. We strongly recom-
mend that all primary care physicians dealing with diabetic 
patients should monitor the signs and symptoms of nervous 
system abnormalities and include NCS as part of early dia-
betes management.
Table 1. Results of nerve conduction studies in diabetic patients. Twelve patients showed abnormalities in neurographic  
readings, which suggested neuropathy 
Patient
No.
Nerve distribution of ab-
normalities
Type of abnormalities Results 
SNCS MNCS
1 R median ↓ CNAP amplitude, ↓ NCV 
finger – wrist segment
↑ DML carpal tunnel syndrome
12 L ulnar, R median, L sural, 
R superficial peroneal
↓ CNAP amplitude none sensory, axonal polyneu-
ropathy
4 R median ↓ CNAP amplitude, 
↓ NCV finger – wrist segment
↑ DML carpal tunnel syndrome
6 R median, L sural,  
R superficial peroneal
↓ CNAP amplitude none sensory, axonal polyneu-
ropathy
9 R median ↓ CNAP amplitude, 
↓ NCV finger – wrist segment
↑ DML carpal tunnel syndrome
10 R median, L sural,  
R superficial peroneal 
↓ CNAP amplitude none sensory, axonal polyneu-
ropathy
11 L ulnar, R median, L sural, 
R superficial peroneal 
↓ CNAP amplitude none sensory, axonal polyneu-
ropathy
13 R median, L sural,  
R superficial peroneal 
↓ CNAP amplitude none sensory, axonal polyneu-
ropathy
15 R median, L sural,  
R superficial peroneal 
↓ CNAP amplitude none sensory, axonal polyneu-
ropathy
16 L ulnar, R median,  
R superficial peroneal
↓ CNAP amplitude none sensory, axonal polyneu-
ropathy
18 L ulnar, R median, L sural, 
L tibial, R peroneal,  
R superficial peroneal
↓ CNAP amplitude
unobtainable L sural and  
R superficial peroneal
↓ CMAP amplitude
↓ NCV ↑ DML
sensory and motor polyneu-
ropathy
20 L ulnar, R median, L sural, 
R peroneal, R superficial 
peroneal
↓ CNAP amplitude
unobtainable R superficial 
peroneal
↓ CMAP amplitude
↓ NCV ↑ DML
sensory and motor polyneu-
ropathy
↓ – decrease; ↑ – prolongation; L – left; R – right; SNCS – sensory nerve conduction study; MNCS – motor nerve conduction study; CNAP 
– compound nerve action potential; NCV – nerve conduction velocity in meters/second; DML – distal motor latency in milliseconds; CMAP 
– compound muscle action potential. 
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